AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-91758657/maxygen-receives-2-4.html" title="Facts and information about Maxygen receives $2.4 million grant to develop cross protective vaccines.(Brief Article)">Maxygen receives $2.4 million grant to develop cross protective vaccines.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Vaccine Weekly are available.
Frequently asked questions about RSS feeds
Maxygen receives $2.4 million grant to develop cross protective vaccines.(Brief Article)
2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Maxygen, Inc., (MAXY) announced the receipt of a $2.4 million, 3-year grant from the U.S. Army Medical Research and Materiel Command to develop cross-protective vaccines against three types of encephalitis virus.
Maxygen scientists will be working in collaboration with scientists at the U.S. Army Medical Research Institute for Infectious Diseases to develop a single vaccine antigen that is capable of protecting against Venezuelan, Western, and Eastern equine encephalitis viruses. These viruses can cause infections in humans resulting in a spectrum of diseases from inapparent infection to severe neurological consequences including death.
"We are pleased to have another ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Maxygen receives $2.4 million grant to develop cross protective vaccines.
- Newspaper article from: Vector & Zoonosis Week September 23, 2002 700+ words
...Materiel Command to develop cross-protective vaccines against three types of encephalitis...vaccine designed to generate cross protective immunity against variants...conducting research to create cross protective vaccines for three other viral diseases...
- Press Release: Maxygen receives $2.4 M grant to develop cross protective...
- News wire article from: Asia Africa Intelligence Wire August 22, 2002 700+ words
...receipt of a $2.4 M, three-year grant from the US Army Medical Research and Materiel Command to develop cross protective vaccines against three types of encephalitis virus. Maxygen scientists will be working in collaboration with scientists...
- Novavax Reports Positive Preclinical Results for a Novel, Broadly...
- Press release article from: PR Newswire February 19, 2009 700+ words
...believe that our recombinant VLP technology has the potential to be a powerful, new approach to develop broadly cross-protective vaccines. This approach may provide a viable strategy for pre-pandemic vaccination without an adjuvant and for stockpiling...
- Sanofi Pasteur MSD announces cross-protective effect and prevention of...
- News wire article from: Chemical Business Newsbase August 18, 2008 700+ words
...Gardasil has been updated to include a cross-protective effect in preventing precancerous...directly targeted by the vaccine. Cross-protective efficacy was demonstrated in particular...first and only HPV vaccine to have a cross-protective effect added to its product information...
- PowderMed's DNA-based flu vaccine shows cross-protective immunity against...
- News wire article from: Chemical Business Newsbase December 19, 2005 700+ words
...based vaccines and immunotherapeutics company PowderMed has shown that its H3/Panama DNA-based influenza vaccine shows cross-protective immunity against both an homologous H3 flu strain as well as four drifted heterologous H3 strains. This suggests that...
- PowderMed's DNA-Based Flu Vaccine Shows Cross-Protective Immunity against...
- Press release article from: Business Wire December 19, 2005 700+ words
...based vaccines and immunotherapeutics company PowderMed has shown that its H3/Panama DNA-based influenza vaccine shows cross-protective immunity against both an homologous H3 flu strain as well as four drifted heterologous H3 strains. This suggests that...
- Cross-protective immune responses induced in rhesus macaques by immunization...
- Newspaper article from: AIDS Weekly Clements, J.E. Montelaro, R.C. Zink, M.C. Amedee, A.M. Miller, S. Tichel, A.M. Jagerski, B. Hauer, D. Martin, L.N. Bohm, R.P. Murpheycorb, M. May 22, 1995 700+ words
According to the authors' abstract of an article published in Journal of Virology, "The simian immunodeficiency virus (SIV) macaque model of AIDS has provided a valuable system with which to investigate vaccine approaches for protection against human immunodeficiency virus type 1 (HIV-1) infection.
- UCSB researchers develop cross-protective vaccine.
- Newspaper article from: Cancer Vaccine Week November 3, 2008 700+ words
Doctors have always hoped that scientists might one day create a vaccination that would treat a broad spectrum of maladies. They could only imagine that there might be one vaccine that would protect against, say, 2,500 strains of Salmonella. And what if that same vaccine could help protect the
- Data show hope for cross-protective flu vaccine.(Wednesday, May 3)
- Newspaper article from: BioWorld Week May 8, 2006 700+ words
Preclinical data from Vical Inc. gave strength to the theory that a universal vaccine could protect against several flu strains, including those feared to cause a deadly pandemic, and the company's stock was lifted by 30.7 percent. Shares (NASDAQ:VICL) shot up $1.69 May 2 to close at $7.19, after
- UC Santa Barbara Researchers Develop Cross-Protective Vaccine.
- News wire article from: Ascribe Higher Education News Service October 21, 2008 700+ words
Byline: University of California, Santa Barbara SANTA BARBARA, Calif., Oct. 21 (AScribe Newswire) -- Doctors have always hoped that scientists might one day create a vaccination that would treat a broad spectrum of maladies. They could only imagine that there might be one vaccine that would protect
Source: HighBeam Research, Maxygen receives $2.4 million grant to develop cross protective...